Enlivex Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENLV and other ETFs, options, and stocks.

About ENLV

Enlivex Therapeutics Ltd. is a clinical stage macrophage reprogramming immunotherapy company, which develops Allocetra,a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded on January 22, 2012 and is headquartered in Nes-Ziona, Israel. 

CEO
Oren Hershkovitz
CEOOren Hershkovitz
Employees
71
Employees71
Headquarters
Nes-Ziona, Tel Aviv
HeadquartersNes-Ziona, Tel Aviv
Founded
2012
Founded2012
Employees
71
Employees71

ENLV Key Statistics

Market cap
81.15M
Market cap81.15M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
25.01K
Average volume25.01K
High today
$4.46
High today$4.46
Low today
$4.25
Low today$4.25
Open price
$4.42
Open price$4.42
Volume
10.78K
Volume10.78K
52 Week high
$9.85
52 Week high$9.85
52 Week low
$3.65
52 Week low$3.65

ENLV Earnings

-$0.54
-$0.36
-$0.18
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 18, Pre-Market
ActualExpected Nov 18, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.